NRX Pharmaceuticals (NRXP)

• Market cap: $59.8M
• 1 day: 4.93%
• 5 days: -6.99%
• 1 month: -33.64%
• 3 months: -15.81%
• 6 months: -19.01%
• Year to date: -28.76%
• 1 year: 73.17%
• 5 years: -98.03%
• 10 years: -97.78%
• Sector: Healthcare
• Industry: Biotechnology

About: NRX Pharmaceuticals Inc is a clinical-stage, small-molecule pharmaceutical company that develops and plans to distribute novel therapeutics for the treatment of central nervous system disorders and life-threatening pulmonary diseases. It has announced the commercialization of ZYESAMI (Aviptadil), an application for COVID-related respiratory failure. The company is also developing NRX-100/101, the first sequential drug regimen for bipolar depression in patients with acute suicidal ideation and behavior.